Published in Lab Business Week, February 4th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Elan.
Report 1: Elan Corporation, plc (ELN) announced its third quarter 2006 financial results.
Commenting on Elan's business, Kelly Martin, Elan's president and chief executive officer, said, "The third quarter provided further evidence of progress in key areas.
"We are encouraged by the initial results in the relaunch of Tysabri for MS in the U.S. market and the launch in the European markets. As patients and physicians seek greater efficacy and therapeutic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week